• Intellectual Property, Technology Transfer, and Local Production to Increase Access to Medicines 

      KATSIOLOUDES, MARIOS I. (2018 , Presentation)
      Outlines: * INTELLECTUAL PROPERTY (IP): THE CONCEPT *QATAR and IP * WIPO *QATAR’S OTHER MEMBERSHIPS *Patent Cooperation Treaty *INTELLECTUAL PROPERTY LAWS OF QATAR * TECHNOLOGY TRANSFER (TT) IN THE PHARMACEUTICAL ...
    • Medication Sector in Qatar: Hand in Hand Facing the Blockade 

      Fakhro, Jassim; Al-Derham, Hassan; Diab, Mohammad; Al-Khal, Abdul Latif; Sulaiti, Ahmed; ... more authors (2018 , Conference Program)
      Conference agenda
    • National Strategic Stockpile for the Health Sector 

      Mohd, Alhajri (2018 , Presentation)
      Outline: - Introduction – Why Stockpile? National Strategic Stockpiles project (NSS) - Project Aim - Expected Outcomes - Proposal Process - Project Management Plan - Implementation steps - The blockade Challenges ...
    • Pharmaceutical Industry in Qatar 

      Al-Mohannadi, Ahmed (2018 , Presentation)
      Overview: * Current Pharma Market Share of Qatar * Consequences of depending on other countries * Main challenges and barriers of local production of medicines in Qatar * How to overcome the challenges and barriers * ...
    • The Right to Health under International Law 

      Konstantinidis, Ioannis (2018 , Presentation)
      Outline: * The International Legal Framework Surrounding the Right to Health * Key Aspects of the Right to Health * Obligations on States towards the Right to Health *Embargos and the Right to Health – Access to Medicines
    • Supply of Medications and Patient Access to Different Therapies: HMC Experience 

      Al-Boloshi, Pharmacist Zakiya (2018 , Presentation)
      Outlines: • Drug supply aims and service . • Process of Ordering and Reordering of Medication in HMC. • HMC Formulary. • Medication Shortage . • Blockade and its Effects on Supplying of Medication.
    • WHO Model List Of Essential Medicines and countries Health response during Embargo 

      Alhajri, Mohd (2018 , Presentation)
      Outline: A. Challenges and barriers to medicines availability in crisis. B. Access to domestic and global market of generic medicines. C. WHO Model List Of Essential Medicines. D. Case example and the way forward from ...